Cargando…

System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019

OBJECTIVE: To determine whether there were improvements in rheumatology care for rheumatoid arthritis (RA) between 2002 and 2019 in Ontario, Canada, and to evaluate the impact of rheumatologist regional supply on access. METHODS: We conducted a population-based retrospective study of all individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Barber, Claire E. H., Lacaille, Diane, Croxford, Ruth, Barnabe, Cheryl, Marshall, Deborah A., Abrahamowicz, Michal, Xie, Hui, Avina-Zubieta, J. Antonio, Esdaile, John M., Hazlewood, Glen, Faris, Peter, Katz, Steven, MacMullan, Paul, Mosher, Dianne, Widdifield, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793576/
https://www.ncbi.nlm.nih.gov/pubmed/36572934
http://dx.doi.org/10.1186/s41927-022-00315-6
_version_ 1784859871224528896
author Barber, Claire E. H.
Lacaille, Diane
Croxford, Ruth
Barnabe, Cheryl
Marshall, Deborah A.
Abrahamowicz, Michal
Xie, Hui
Avina-Zubieta, J. Antonio
Esdaile, John M.
Hazlewood, Glen
Faris, Peter
Katz, Steven
MacMullan, Paul
Mosher, Dianne
Widdifield, Jessica
author_facet Barber, Claire E. H.
Lacaille, Diane
Croxford, Ruth
Barnabe, Cheryl
Marshall, Deborah A.
Abrahamowicz, Michal
Xie, Hui
Avina-Zubieta, J. Antonio
Esdaile, John M.
Hazlewood, Glen
Faris, Peter
Katz, Steven
MacMullan, Paul
Mosher, Dianne
Widdifield, Jessica
author_sort Barber, Claire E. H.
collection PubMed
description OBJECTIVE: To determine whether there were improvements in rheumatology care for rheumatoid arthritis (RA) between 2002 and 2019 in Ontario, Canada, and to evaluate the impact of rheumatologist regional supply on access. METHODS: We conducted a population-based retrospective study of all individuals diagnosed with RA between January 1, 2002 and December 31, 2019. Performance measures evaluated were: (i) percentage of RA patients seen by a rheumatologist within one year of diagnosis; and (ii) percentage of individuals with RA aged 66 years and older (whose prescription drugs are publicly funded) dispensed a disease modifying anti-rheumatic drug (DMARD) within 30 days after initial rheumatologist visit. Logistic regression was used to assess whether performance improved over time and whether the improvements differed by rheumatology supply, dichotomized as < 1 rheumatologist per 75,000 adults versus ≥1 per 75,000. RESULTS: Among 112,494 incident RA patients, 84% saw a rheumatologist within one year: The percentage increased over time (adjusted odds ratio (OR) 2019 vs. 2002 = 1.43, p < 0.0001) and was consistently higher in regions with higher rheumatologist supply (OR = 1.73, 95% CI 1.67–1.80). Among seniors who were seen by a rheumatologist within 1 year of their diagnosis the likelihood of timely DMARD treatment was lower among individuals residing in regions with higher rheumatologist supply (OR = 0.90 95% CI 0.83–0.97). These trends persisted after adjusting for other covariates. CONCLUSION: While access to rheumatologists and treatment improved over time, shortcomings remain, particularly for DMARD use. Patients residing in regions with higher rheumatology supply were more likely to access care but less likely to receive timely treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-022-00315-6.
format Online
Article
Text
id pubmed-9793576
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97935762022-12-28 System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019 Barber, Claire E. H. Lacaille, Diane Croxford, Ruth Barnabe, Cheryl Marshall, Deborah A. Abrahamowicz, Michal Xie, Hui Avina-Zubieta, J. Antonio Esdaile, John M. Hazlewood, Glen Faris, Peter Katz, Steven MacMullan, Paul Mosher, Dianne Widdifield, Jessica BMC Rheumatol Research OBJECTIVE: To determine whether there were improvements in rheumatology care for rheumatoid arthritis (RA) between 2002 and 2019 in Ontario, Canada, and to evaluate the impact of rheumatologist regional supply on access. METHODS: We conducted a population-based retrospective study of all individuals diagnosed with RA between January 1, 2002 and December 31, 2019. Performance measures evaluated were: (i) percentage of RA patients seen by a rheumatologist within one year of diagnosis; and (ii) percentage of individuals with RA aged 66 years and older (whose prescription drugs are publicly funded) dispensed a disease modifying anti-rheumatic drug (DMARD) within 30 days after initial rheumatologist visit. Logistic regression was used to assess whether performance improved over time and whether the improvements differed by rheumatology supply, dichotomized as < 1 rheumatologist per 75,000 adults versus ≥1 per 75,000. RESULTS: Among 112,494 incident RA patients, 84% saw a rheumatologist within one year: The percentage increased over time (adjusted odds ratio (OR) 2019 vs. 2002 = 1.43, p < 0.0001) and was consistently higher in regions with higher rheumatologist supply (OR = 1.73, 95% CI 1.67–1.80). Among seniors who were seen by a rheumatologist within 1 year of their diagnosis the likelihood of timely DMARD treatment was lower among individuals residing in regions with higher rheumatologist supply (OR = 0.90 95% CI 0.83–0.97). These trends persisted after adjusting for other covariates. CONCLUSION: While access to rheumatologists and treatment improved over time, shortcomings remain, particularly for DMARD use. Patients residing in regions with higher rheumatology supply were more likely to access care but less likely to receive timely treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-022-00315-6. BioMed Central 2022-12-27 /pmc/articles/PMC9793576/ /pubmed/36572934 http://dx.doi.org/10.1186/s41927-022-00315-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Barber, Claire E. H.
Lacaille, Diane
Croxford, Ruth
Barnabe, Cheryl
Marshall, Deborah A.
Abrahamowicz, Michal
Xie, Hui
Avina-Zubieta, J. Antonio
Esdaile, John M.
Hazlewood, Glen
Faris, Peter
Katz, Steven
MacMullan, Paul
Mosher, Dianne
Widdifield, Jessica
System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019
title System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019
title_full System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019
title_fullStr System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019
title_full_unstemmed System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019
title_short System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019
title_sort system-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in ontario, canada, 2002–2019
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793576/
https://www.ncbi.nlm.nih.gov/pubmed/36572934
http://dx.doi.org/10.1186/s41927-022-00315-6
work_keys_str_mv AT barberclaireeh systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019
AT lacaillediane systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019
AT croxfordruth systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019
AT barnabecheryl systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019
AT marshalldeboraha systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019
AT abrahamowiczmichal systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019
AT xiehui systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019
AT avinazubietajantonio systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019
AT esdailejohnm systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019
AT hazlewoodglen systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019
AT farispeter systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019
AT katzsteven systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019
AT macmullanpaul systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019
AT mosherdianne systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019
AT widdifieldjessica systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019